Global Over The Counter (OTC) Drugs Market Insights and Forecast to 2028

Publisher Name :
Date: 28-Jan-2022
No. of pages: 111
Inquire Before Buying

Over The Counter (OTC) Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Over The Counter (OTC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Analgesics

- Dermatology Products

- Gastrointestinal Products

- Vitamins, Mineral, and Supplements (VMS)

- Weight Loss/Dietary Products

- Ophthalmic Products

- Sleeping Aids

- Others

Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacy

- Others

By Company

- Bayer AG

- Merck KGaA

- Novartis

- Johnson & Johnson

- GlaxoSmithKline

- Alkem Laboratories

- Teva Pharmaceutical Industries

- Pfizer

- Sun Pharma

- Allergan

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Over The Counter (OTC) Drugs Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Analgesics
1.2.3 Dermatology Products
1.2.4 Gastrointestinal Products
1.2.5 Vitamins, Mineral, and Supplements (VMS)
1.2.6 Weight Loss/Dietary Products
1.2.7 Ophthalmic Products
1.2.8 Sleeping Aids
1.2.9 Others
1.3 Market by Application
1.3.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Over The Counter (OTC) Drugs Market Perspective (2017-2028)
2.2 Over The Counter (OTC) Drugs Growth Trends by Region
2.2.1 Over The Counter (OTC) Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Over The Counter (OTC) Drugs Historic Market Size by Region (2017-2022)
2.2.3 Over The Counter (OTC) Drugs Forecasted Market Size by Region (2023-2028)
2.3 Over The Counter (OTC) Drugs Market Dynamics
2.3.1 Over The Counter (OTC) Drugs Industry Trends
2.3.2 Over The Counter (OTC) Drugs Market Drivers
2.3.3 Over The Counter (OTC) Drugs Market Challenges
2.3.4 Over The Counter (OTC) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Over The Counter (OTC) Drugs Players by Revenue
3.1.1 Global Top Over The Counter (OTC) Drugs Players by Revenue (2017-2022)
3.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Over The Counter (OTC) Drugs Revenue
3.4 Global Over The Counter (OTC) Drugs Market Concentration Ratio
3.4.1 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2021
3.5 Over The Counter (OTC) Drugs Key Players Head office and Area Served
3.6 Key Players Over The Counter (OTC) Drugs Product Solution and Service
3.7 Date of Enter into Over The Counter (OTC) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Over The Counter (OTC) Drugs Breakdown Data by Type
4.1 Global Over The Counter (OTC) Drugs Historic Market Size by Type (2017-2022)
4.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2023-2028)
5 Over The Counter (OTC) Drugs Breakdown Data by Application
5.1 Global Over The Counter (OTC) Drugs Historic Market Size by Application (2017-2022)
5.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Over The Counter (OTC) Drugs Market Size (2017-2028)
6.2 North America Over The Counter (OTC) Drugs Market Size by Type
6.2.1 North America Over The Counter (OTC) Drugs Market Size by Type (2017-2022)
6.2.2 North America Over The Counter (OTC) Drugs Market Size by Type (2023-2028)
6.2.3 North America Over The Counter (OTC) Drugs Market Share by Type (2017-2028)
6.3 North America Over The Counter (OTC) Drugs Market Size by Application
6.3.1 North America Over The Counter (OTC) Drugs Market Size by Application (2017-2022)
6.3.2 North America Over The Counter (OTC) Drugs Market Size by Application (2023-2028)
6.3.3 North America Over The Counter (OTC) Drugs Market Share by Application (2017-2028)
6.4 North America Over The Counter (OTC) Drugs Market Size by Country
6.4.1 North America Over The Counter (OTC) Drugs Market Size by Country (2017-2022)
6.4.2 North America Over The Counter (OTC) Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Over The Counter (OTC) Drugs Market Size (2017-2028)
7.2 Europe Over The Counter (OTC) Drugs Market Size by Type
7.2.1 Europe Over The Counter (OTC) Drugs Market Size by Type (2017-2022)
7.2.2 Europe Over The Counter (OTC) Drugs Market Size by Type (2023-2028)
7.2.3 Europe Over The Counter (OTC) Drugs Market Share by Type (2017-2028)
7.3 Europe Over The Counter (OTC) Drugs Market Size by Application
7.3.1 Europe Over The Counter (OTC) Drugs Market Size by Application (2017-2022)
7.3.2 Europe Over The Counter (OTC) Drugs Market Size by Application (2023-2028)
7.3.3 Europe Over The Counter (OTC) Drugs Market Share by Application (2017-2028)
7.4 Europe Over The Counter (OTC) Drugs Market Size by Country
7.4.1 Europe Over The Counter (OTC) Drugs Market Size by Country (2017-2022)
7.4.2 Europe Over The Counter (OTC) Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size (2017-2028)
8.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type
8.2.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Over The Counter (OTC) Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application
8.3.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Over The Counter (OTC) Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region
8.4.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Over The Counter (OTC) Drugs Market Size (2017-2028)
9.2 Latin America Over The Counter (OTC) Drugs Market Size by Type
9.2.1 Latin America Over The Counter (OTC) Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Over The Counter (OTC) Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Over The Counter (OTC) Drugs Market Share by Type (2017-2028)
9.3 Latin America Over The Counter (OTC) Drugs Market Size by Application
9.3.1 Latin America Over The Counter (OTC) Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Over The Counter (OTC) Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Over The Counter (OTC) Drugs Market Share by Application (2017-2028)
9.4 Latin America Over The Counter (OTC) Drugs Market Size by Country
9.4.1 Latin America Over The Counter (OTC) Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Over The Counter (OTC) Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size (2017-2028)
10.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type
10.2.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Over The Counter (OTC) Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application
10.3.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Over The Counter (OTC) Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country
10.4.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Over The Counter (OTC) Drugs Introduction
11.1.4 Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
11.1.5 Bayer AG Recent Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Over The Counter (OTC) Drugs Introduction
11.2.4 Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
11.2.5 Merck KGaA Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Over The Counter (OTC) Drugs Introduction
11.3.4 Novartis Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
11.4.5 Johnson & Johnson Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Alkem Laboratories
11.6.1 Alkem Laboratories Company Details
11.6.2 Alkem Laboratories Business Overview
11.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Introduction
11.6.4 Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
11.6.5 Alkem Laboratories Recent Developments
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Details
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
11.7.5 Teva Pharmaceutical Industries Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Over The Counter (OTC) Drugs Introduction
11.8.4 Pfizer Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
11.8.5 Pfizer Recent Developments
11.9 Sun Pharma
11.9.1 Sun Pharma Company Details
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Over The Counter (OTC) Drugs Introduction
11.9.4 Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
11.9.5 Sun Pharma Recent Developments
11.10 Allergan
11.10.1 Allergan Company Details
11.10.2 Allergan Business Overview
11.10.3 Allergan Over The Counter (OTC) Drugs Introduction
11.10.4 Allergan Revenue in Over The Counter (OTC) Drugs Business (2017-2022)
11.10.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Analgesics
Table 3. Key Players of Dermatology Products
Table 4. Key Players of Gastrointestinal Products
Table 5. Key Players of Vitamins, Mineral, and Supplements (VMS)
Table 6. Key Players of Weight Loss/Dietary Products
Table 7. Key Players of Ophthalmic Products
Table 8. Key Players of Sleeping Aids
Table 9. Key Players of Others
Table 10. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 11. Global Over The Counter (OTC) Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 12. Global Over The Counter (OTC) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 13. Global Over The Counter (OTC) Drugs Market Share by Region (2017-2022)
Table 14. Global Over The Counter (OTC) Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 15. Global Over The Counter (OTC) Drugs Market Share by Region (2023-2028)
Table 16. Over The Counter (OTC) Drugs Market Trends
Table 17. Over The Counter (OTC) Drugs Market Drivers
Table 18. Over The Counter (OTC) Drugs Market Challenges
Table 19. Over The Counter (OTC) Drugs Market Restraints
Table 20. Global Over The Counter (OTC) Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 21. Global Over The Counter (OTC) Drugs Revenue Share by Players (2017-2022)
Table 22. Global Top Over The Counter (OTC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over The Counter (OTC) Drugs as of 2021)
Table 23. Ranking of Global Top Over The Counter (OTC) Drugs Companies by Revenue (US$ Million) in 2021
Table 24. Global 5 Largest Players Market Share by Over The Counter (OTC) Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Over The Counter (OTC) Drugs Product Solution and Service
Table 27. Date of Enter into Over The Counter (OTC) Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Over The Counter (OTC) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 30. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2017-2022)
Table 31. Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 32. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2023-2028)
Table 33. Global Over The Counter (OTC) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 34. Global Over The Counter (OTC) Drugs Revenue Share by Application (2017-2022)
Table 35. Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 36. Global Over The Counter (OTC) Drugs Revenue Share by Application (2023-2028)
Table 37. North America Over The Counter (OTC) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 38. North America Over The Counter (OTC) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 39. North America Over The Counter (OTC) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 40. North America Over The Counter (OTC) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 41. North America Over The Counter (OTC) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 42. North America Over The Counter (OTC) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 43. Europe Over The Counter (OTC) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 44. Europe Over The Counter (OTC) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 45. Europe Over The Counter (OTC) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 46. Europe Over The Counter (OTC) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 47. Europe Over The Counter (OTC) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 48. Europe Over The Counter (OTC) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 49. Asia Pacific Over The Counter (OTC) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 50. Asia Pacific Over The Counter (OTC) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 51. Asia Pacific Over The Counter (OTC) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 52. Asia Pacific Over The Counter (OTC) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 53. Asia Pacific Over The Counter (OTC) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 54. Asia Pacific Over The Counter (OTC) Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 55. Latin America Over The Counter (OTC) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 56. Latin America Over The Counter (OTC) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 57. Latin America Over The Counter (OTC) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 58. Latin America Over The Counter (OTC) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 59. Latin America Over The Counter (OTC) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 60. Latin America Over The Counter (OTC) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Over The Counter (OTC) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Over The Counter (OTC) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Over The Counter (OTC) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Over The Counter (OTC) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 65. Middle East and Africa Over The Counter (OTC) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 66. Middle East and Africa Over The Counter (OTC) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 67. Bayer AG Company Details
Table 68. Bayer AG Business Overview
Table 69. Bayer AG Over The Counter (OTC) Drugs Product
Table 70. Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million)
Table 71. Bayer AG Recent Developments
Table 72. Merck KGaA Company Details
Table 73. Merck KGaA Business Overview
Table 74. Merck KGaA Over The Counter (OTC) Drugs Product
Table 75. Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million)
Table 76. Merck KGaA Recent Developments
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Over The Counter (OTC) Drugs Product
Table 80. Novartis Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million)
Table 81. Novartis Recent Developments
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Over The Counter (OTC) Drugs Product
Table 85. Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million)
Table 86. Johnson & Johnson Recent Developments
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Over The Counter (OTC) Drugs Product
Table 90. GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million)
Table 91. GlaxoSmithKline Recent Developments
Table 92. Alkem Laboratories Company Details
Table 93. Alkem Laboratories Business Overview
Table 94. Alkem Laboratories Over The Counter (OTC) Drugs Product
Table 95. Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million)
Table 96. Alkem Laboratories Recent Developments
Table 97. Teva Pharmaceutical Industries Company Details
Table 98. Teva Pharmaceutical Industries Business Overview
Table 99. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product
Table 100. Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million)
Table 101. Teva Pharmaceutical Industries Recent Developments
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Over The Counter (OTC) Drugs Product
Table 105. Pfizer Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million)
Table 106. Pfizer Recent Developments
Table 107. Sun Pharma Company Details
Table 108. Sun Pharma Business Overview
Table 109. Sun Pharma Over The Counter (OTC) Drugs Product
Table 110. Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million)
Table 111. Sun Pharma Recent Developments
Table 112. Allergan Company Details
Table 113. Allergan Business Overview
Table 114. Allergan Over The Counter (OTC) Drugs Product
Table 115. Allergan Revenue in Over The Counter (OTC) Drugs Business (2017-2022) & (US$ Million)
Table 116. Allergan Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Over The Counter (OTC) Drugs Market Share by Type: 2021 VS 2028
Figure 2. Analgesics Features
Figure 3. Dermatology Products Features
Figure 4. Gastrointestinal Products Features
Figure 5. Vitamins, Mineral, and Supplements (VMS) Features
Figure 6. Weight Loss/Dietary Products Features
Figure 7. Ophthalmic Products Features
Figure 8. Sleeping Aids Features
Figure 9. Others Features
Figure 10. Global Over The Counter (OTC) Drugs Market Share by Application: 2021 VS 2028
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Online Pharmacy Case Studies
Figure 14. Others Case Studies
Figure 15. Over The Counter (OTC) Drugs Report Years Considered
Figure 16. Global Over The Counter (OTC) Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Over The Counter (OTC) Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Over The Counter (OTC) Drugs Market Share by Region: 2021 VS 2028
Figure 19. Global Over The Counter (OTC) Drugs Market Share by Players in 2021
Figure 20. Global Top Over The Counter (OTC) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over The Counter (OTC) Drugs as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Over The Counter (OTC) Drugs Revenue in 2021
Figure 22. North America Over The Counter (OTC) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 23. North America Over The Counter (OTC) Drugs Market Size Market Share by Type (2017-2028)
Figure 24. North America Over The Counter (OTC) Drugs Market Size Market Share by Application (2017-2028)
Figure 25. North America Over The Counter (OTC) Drugs Market Size Share by Country (2017-2028)
Figure 26. United States Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Canada Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Europe Over The Counter (OTC) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 29. Europe Over The Counter (OTC) Drugs Market Size Market Share by Type (2017-2028)
Figure 30. Europe Over The Counter (OTC) Drugs Market Size Market Share by Application (2017-2028)
Figure 31. Europe Over The Counter (OTC) Drugs Market Size Share by Country (2017-2028)
Figure 32. Germany Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Over The Counter (OTC) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 39. Asia Pacific Over The Counter (OTC) Drugs Market Size Market Share by Type (2017-2028)
Figure 40. Asia Pacific Over The Counter (OTC) Drugs Market Size Market Share by Application (2017-2028)
Figure 41. Asia Pacific Over The Counter (OTC) Drugs Market Size Share by Region (2017-2028)
Figure 42. China Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Japan Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. South Korea Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Southeast Asia Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. India Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Australia Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Latin America Over The Counter (OTC) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Latin America Over The Counter (OTC) Drugs Market Size Market Share by Type (2017-2028)
Figure 50. Latin America Over The Counter (OTC) Drugs Market Size Market Share by Application (2017-2028)
Figure 51. Latin America Over The Counter (OTC) Drugs Market Size Share by Country (2017-2028)
Figure 52. Mexico Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Brazil Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa Over The Counter (OTC) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Over The Counter (OTC) Drugs Market Size Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Over The Counter (OTC) Drugs Market Size Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Over The Counter (OTC) Drugs Market Size Share by Country (2017-2028)
Figure 58. Turkey Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. UAE Over The Counter (OTC) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 61. Bayer AG Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2017-2022)
Figure 62. Merck KGaA Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2017-2022)
Figure 63. Novartis Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2017-2022)
Figure 64. Johnson & Johnson Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2017-2022)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2017-2022)
Figure 66. Alkem Laboratories Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2017-2022)
Figure 67. Teva Pharmaceutical Industries Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2017-2022)
Figure 68. Pfizer Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2017-2022)
Figure 69. Sun Pharma Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2017-2022)
Figure 70. Allergan Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs